Related references
Note: Only part of the references are listed.Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency
Amelie Dureault et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Aspergillus felis in Patient with Chronic Granulomatous Disease
Olivier Paccoud et al.
EMERGING INFECTIOUS DISEASES (2019)
Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection
Eemke L. Assendorp et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
The Aspergillus fumigatus Sialidase (Kdnase) Contributes to Cell Wall Integrity and Virulence in Amphotericin B-Treated Mice
Jason R. Nesbitt et al.
FRONTIERS IN MICROBIOLOGY (2018)
Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins
Rajashri Shende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells
Hetty Jolink et al.
JOURNAL OF INFECTION (2017)
Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells
Emmanuel Stephen-Victor et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Immunotherapeutic approaches to treatment of fungal diseases
Darius Armstrong-James et al.
LANCET INFECTIOUS DISEASES (2017)
Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects
Roel P. Gazendam et al.
JOURNAL OF IMMUNOLOGY (2016)
STAT3 signaling in immunity
Emily J. Hillmer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Extrapulmonary Aspergillus infection in patients with CARD9 deficiency
Nikolaus Rieber et al.
JCI INSIGHT (2016)
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Corine E. Delsing et al.
BMC INFECTIOUS DISEASES (2014)
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
R. Agarwal et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
Renal Allograft Recipients Fail to Increase Interferon-γ During Invasive Fungal Diseases
D. Armstrong-James et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan Synthesis
Cecile Clavaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome Molecular, Cellular, and Clinical Features From a French National Survey
Marie-Olivia Chandesris et al.
MEDICINE (2012)
Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells
Masako Saito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Epidemiology and Outcome of Invasive Fungal Diseases in Patients With Chronic Granulomatous Disease A Multicenter Study in France
Julien Beaute et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Exogenous Interferon-γ Immunotherapy for Invasive Fungal Infections in Kidney Transplant Patients
D. Armstrong-James et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency
F. L. van de Veerdonk et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
Louis Y. A. Chai et al.
IMMUNOLOGY (2010)
Invasive fungal disease in autosomal-dominant hyper-IgE syndrome
Donald C. Vinh et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome
Yoshiyuki Minegishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Impaired Interferon-γ Responses, Increased Interleukin-17 Expression, and a Tumor Necrosis Factor-α Transcriptional Program in Invasive Aspergillosis
Darius P. H. Armstrong-James et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
Ludovic de Beaucoudrey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Joshua D. Milner et al.
NATURE (2008)
STAT3 mutations in the hyper-IgE syndrome
Steven M. Holland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Yoshiyuki Minegishi et al.
NATURE (2007)
Recombinant antigens as diagnostic markers for aspergillosis
Jacqueline Sarfati et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus
MED Ferreira et al.
EUKARYOTIC CELL (2006)
Severely impaired IL-12/IL-18/IFNγ axis in patients with hyper IgE syndrome
MG Netea et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies
H Hebart et al.
BLOOD (2002)
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver
T Alonzi et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
T Hirano et al.
ONCOGENE (2000)
Share Paper
